• Multaq®
• Dronedarone
• Multaq® 400 mg
• Multaq® and Atrial Fibrillation
• Multaq® Dosage
• Multaq® Drug
• Multaq® Drug Interactions
• Multaq® Heart Failure
• Multaq® Heart Medication
• Multaq® Hepatic Injury
• Multaq® Injury
• Multaq® Kidney Failure
• Multaq® Lawsuit
• Multaq® Lawyer
• Multaq® Liver Failure
• Multaq® Liver Injury: FDA Warning
• Multaq® Liver Injury Lawsuit
• Multaq® Liver Injury Lawyer
• Multaq® Liver Toxicity
• Multaq® Side Effects
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

If you believe that you've been harmed by Multaq®, contact our Multaq® lawyers to find out if you qualify to seek financial compensation for your pain and suffering.

Multaq® Health Risks

Multaq® has numerous risks for the patients who take it. These include:

• Heart failure
• Lethal arrhythmias (irregular heartbeats)
• Serious interactions with other drugs
• Impaired kidney function

Multaq® Warnings and Side Effects

The label insert that comes with the medication has a "black box" warning required by the Food and Drug Administration (FDA). A black box warning is the most serious caution information that can be carried on a drug's label and it is highlighted by being enclosed in a black-lined square.

The black box warning for Multaq® indicates the drug should not be taken by patients in severe heart failure or moderate heart failure who have recently been hospitalized or referred to a specialized heart failure clinic for the condition. Such patients, the black box warning says, were 2.5 times as likely to die, according to a large drug study called the ANDROMEDA Study.

The most common side effects of Multaq® are:

• Diarrhea
• Nausea
• Abdominal pain
• Vomiting
• Weakness
• New or worsening heart failure
• Lowered blood calcium and magnesium when taken with potassium-depleting diuretics
• Heart arrhythmias
• Fatigue
• Itching
• Liver Problems

In clinical trials, the medication was discontinued because of adverse reactions before the end of the studies in 11.8 percent of the Multaq®-treated patients and in 7.7 percent of the group treated with a placebo.

The Journal Sentinel reported that all six of the authors of a study that led to the approval of the drug by the FDA had financial ties to the company that manufactures Multaq®, Sanofi-Aventis, an international business based in Paris.

Multaq® Injury Claims

With the high number of adverse events (387) and deaths (24) in the short period of time since Multaq® was approved, many lawsuits are sure to be filed against the drug maker Sanofi-Aventis. Multaq® was just approved in July 2009.

Contact a Multaq® Injury Lawyer

If you've suffered a serious side effect while taking Multaq®, contact us to schedule a consultation with a qualified Multaq® lawyer. You may be entitled to compensation for your losses.

"FDA Alert: Multaq® Linked to Liver Failure"

The FDA notified healthcare professionals about new findings that link Multaq® to severe liver injuries, Jan. 14, 2011. The agency said there were two report...

» Read More